891 related articles for article (PubMed ID: 26334030)
1. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
Mohamed R; Jayakumar C; Chen F; Fulton D; Stepp D; Gansevoort RT; Ramesh G
J Am Soc Nephrol; 2016 Mar; 27(3):745-65. PubMed ID: 26334030
[TBL] [Abstract][Full Text] [Related]
2. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
Liang G; Song L; Chen Z; Qian Y; Xie J; Zhao L; Lin Q; Zhu G; Tan Y; Li X; Mohammadi M; Huang Z
Kidney Int; 2018 Jan; 93(1):95-109. PubMed ID: 28750927
[TBL] [Abstract][Full Text] [Related]
4. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy.
Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG
J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771
[TBL] [Abstract][Full Text] [Related]
5. IL-17 deficiency aggravates the streptozotocin-induced diabetic nephropathy through the reduction of autophagosome formation in mice.
Kim KH; Hong GL; Jung DY; Karunasagara S; Jeong WI; Jung JY
Mol Med; 2021 Mar; 27(1):25. PubMed ID: 33691614
[TBL] [Abstract][Full Text] [Related]
6. FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.
Wang XX; Wang D; Luo Y; Myakala K; Dobrinskikh E; Rosenberg AZ; Levi J; Kopp JB; Field A; Hill A; Lucia S; Qiu L; Jiang T; Peng Y; Orlicky D; Garcia G; Herman-Edelstein M; D'Agati V; Henriksen K; Adorini L; Pruzanski M; Xie C; Krausz KW; Gonzalez FJ; Ranjit S; Dvornikov A; Gratton E; Levi M
J Am Soc Nephrol; 2018 Jan; 29(1):118-137. PubMed ID: 29089371
[TBL] [Abstract][Full Text] [Related]
7. Nifuroxazide, a STAT3 inhibitor, mitigates inflammatory burden and protects against diabetes-induced nephropathy in rats.
Said E; Zaitone SA; Eldosoky M; Elsherbiny NM
Chem Biol Interact; 2018 Feb; 281():111-120. PubMed ID: 29291386
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 17A promotes diabetic kidney injury.
Ma J; Li YJ; Chen X; Kwan T; Chadban SJ; Wu H
Sci Rep; 2019 Feb; 9(1):2264. PubMed ID: 30783187
[TBL] [Abstract][Full Text] [Related]
9. The lectin-like domain of thrombomodulin ameliorates diabetic glomerulopathy via complement inhibition.
Wang H; Vinnikov I; Shahzad K; Bock F; Ranjan S; Wolter J; Kashif M; Oh J; Bierhaus A; Nawroth P; Kirschfink M; Conway EM; Madhusudhan T; Isermann B
Thromb Haemost; 2012 Dec; 108(6):1141-53. PubMed ID: 23014597
[TBL] [Abstract][Full Text] [Related]
10. Cinacalcet-mediated activation of the CaMKKβ-LKB1-AMPK pathway attenuates diabetic nephropathy in db/db mice by modulation of apoptosis and autophagy.
Lim JH; Kim HW; Kim MY; Kim TW; Kim EN; Kim Y; Chung S; Kim YS; Choi BS; Kim YS; Chang YS; Kim HW; Park CW
Cell Death Dis; 2018 Feb; 9(3):270. PubMed ID: 29449563
[TBL] [Abstract][Full Text] [Related]
11. Activation of EphA1-Epha receptor axis attenuates diabetic nephropathy in mice.
Li Y; Yan H; Wang F; Huang S; Zhang Y; Wang Z; Zhong M; Zhang W
Biochem Biophys Res Commun; 2017 May; 486(3):693-699. PubMed ID: 28341121
[TBL] [Abstract][Full Text] [Related]
12. Deletion of UNC5B in Kidney Epithelium Exacerbates Diabetic Nephropathy in Mice.
Ranganathan P; Mohamed R; Jayakumar C; Brands MW; Ramesh G
Am J Nephrol; 2015; 41(3):220-30. PubMed ID: 25896231
[TBL] [Abstract][Full Text] [Related]
13. Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes.
Gangadharan Komala M; Gross S; Zaky A; Pollock C; Panchapakesan U
Nephrology (Carlton); 2016 May; 21(5):423-31. PubMed ID: 26375854
[TBL] [Abstract][Full Text] [Related]
14. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
Ichinose K; Maeshima Y; Yamamoto Y; Kitayama H; Takazawa Y; Hirokoshi K; Sugiyama H; Yamasaki Y; Eguchi K; Makino H
Diabetes; 2005 Oct; 54(10):2891-903. PubMed ID: 16186390
[TBL] [Abstract][Full Text] [Related]
16. IL-17 and CD40 ligand synergistically stimulate the chronicity of diabetic nephropathy.
Kuo HL; Huang CC; Lin TY; Lin CY
Nephrol Dial Transplant; 2018 Feb; 33(2):248-256. PubMed ID: 28339909
[TBL] [Abstract][Full Text] [Related]
17. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
Zhang M; Liu M; Xiong M; Gong J; Tan X
J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
[TBL] [Abstract][Full Text] [Related]
18. Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.
Ma J; Wu H; Zhao CY; Panchapakesan U; Pollock C; Chadban SJ
Int J Clin Exp Pathol; 2014; 7(2):481-95. PubMed ID: 24551269
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy.
Lu TC; Wang ZH; Feng X; Chuang PY; Fang W; Shen Y; Levy DE; Xiong H; Chen N; He JC
Kidney Int; 2009 Jul; 76(1):63-71. PubMed ID: 19357722
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice.
Barutta F; Grimaldi S; Franco I; Bellini S; Gambino R; Pinach S; Corbelli A; Bruno G; Rastaldi MP; Aveta T; Hirsch E; Di Marzo V; Gruden G
Kidney Int; 2014 Nov; 86(5):979-90. PubMed ID: 24827776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]